Basic net loss per share is calculated by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period, without consideration for potentially dilutive securities. The Company has included pre-funded warrants to purchase 3,571,435 shares of common stock at an exercise price of $0.00001 in its computation of basic net loss per share. Diluted net loss per share is the same as basic net loss per share for the periods presented since the effects of potentially dilutive securities are antidilutive given the net loss of the Company.

The Company has calculated basic and diluted net loss per share for the three and six months ended June 30, 2025 and 2024 as follows (in thousands, except share and per share data):


	Three Months Ended June 30,						Six Months Ended June 30,
	2025			2024			2025			2024
Numerator:
Net loss	$	(27,019	)	$	(20,337	)	$	(54,502	)	$	(40,043	)
Denominator:
Weighted-average common stock outstanding—basic and diluted		58,015,718			49,548,120			54,092,728			49,500,032
Net loss per common share—basic and diluted	$	(0.47	)	$	(0.41	)	$	(1.01	)	$	(0.81	)

The following potentially dilutive securities were excluded from the computation of the diluted net loss per share for the periods presented because their effect would have been antidilutive:


	Six Months Ended June 30,
	2025		2024
Stock options to purchase common stock		6,860,747		6,049,829
Restricted stock units that vest into common stock		2,824,239		1,758,414
Warrants to purchase common stock		3,826,750		12,686
Total potential dilutive shares		13,511,736		7,820,929